Xu Wu

Company: Harvard Medical School  

Job title: Associate Professor

Seminars:

Workshop C – A Deep-Dive into Identification of Inhibitors of TEAD to Bolster your Drug Development Pipeline 3:00 pm

TEAD Inhibition remains the key method of targeting the Hippo pathway for targeted drug development in YAP dependent cancers. Here we will provide pharmacological insight into potential future drug development candidate inhibitors for TEAD. Attend this Workshop to: Visualize crystal structures of TEAD binding residues with potential candidate compounds Review the therapeutic opportunities and limitations…Read more

day: Pre-Conference Workshop Day